Seattle Genetics Inc.’s(SGEN) MACD indicator has moved into bearish territory with a reading of -0.0335. The Zacks #4 Rank (“Sell”) stock has slipped more than 1% to $8.85 in morning trade. The full-year consensus estimate has worsened by 4 cents over the past 3 months and is now pegged at a loss of $1.13 per share.
“SGEN” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research